Cited by 31Advanced Glycation End Products researchPeripheral Artery Disease ManagementSkin Diseases and Diabetes

Role of ligands of receptor for advanced glycation end products (RAGE) in peripheral artery disease

Yamagishi, Sho-ichi, Matsui, Takanori·2018·Rejuvenation Research

Abstract

Atherosclerotic cardiovascular disease, including peripheral artery disease (PAD), is more common and severe in diabetic patients compared with nondiabetic individuals. Indeed, diabetes is associated with the increased risk of limb amputation and all-cause mortality in patients with symptomatic PAD. Proteins and lipids are nonenzymatically modified by sugars, resulting in the formation and accumulation of advanced glycation end products (AGEs), whose process is accelerated under diabetic conditions, especially patients with a long duration of diabetes. Accumulating evidence shows that nonenzymatic modification by sugars alters the structural integrity of collagens and lipoproteins in large vessels, thereby being involved in vascular stiffness and atherosclerotic plaque instability. Furthermore, engagement of receptor for AGEs (RAGE) with its ligands, such as AGEs, high mobility group box 1, and S100A proteins evokes inflammatory and thrombotic reactions, thus playing a central role in the development and progression of atherosclerotic cardiovascular disease. In this article, we review the pathophysiological role of RAGE ligands in PAD and discuss the clinical utility of measurement of plasma, serum, or tissue RAGE ligands for assessment of the severity and prognosis of PAD. This review suggests that RAGE ligands may be a novel biomarker and also a therapeutic target of PAD, especially in patients with diabetes.

Integrity signals

Registry

Crossref · 10.1089/rej.2017.2025

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yamagishi, S.-I., & Matsui, T.
Affiliations
Kurume University (JP)
Corresponding author
Yamagishi, Sho-ichi
Venue
Rejuvenation Research
Published
2018-10
Volume
21
Issue
5
Pages
456-463
ISSN
  • 1094-5458 (ISSN-L)
  • 1549-1684
  • 1557-8577
OpenAlex
W2797611094
Cited by
31
References
74
Citations by year
2026: 2 · 2025: 6 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 8 · 2018: 1
FWCI
0.52
Type
journal article
Language
en
Open access
closed
Locations
  • Rejuvenation Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (16K07101, 17K08968)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
Keywords
receptor for advanced glycation end products, RAGE ligands, advanced glycation end products, peripheral arterial disease, diabetes mellitus, high mobility group box 1, atherosclerosis, vascular stiffness, inflammation, thrombosis, biomarkers, therapeutic target
MeSH terms
Receptor for Advanced Glycation End Products, Animals, Humans, Ligands, Oxidative Stress, Disease Progression, Peripheral Arterial Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review